This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:psoriasis [08.30.2012] – [Patient interviews] paulalbert | home:diseases:psoriasis [10.17.2018] – [Patient interviews] sallieq | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | < | + | |
====== Psoriasis ====== | ====== Psoriasis ====== | ||
- | Psoriasis is an autoimmune disease that affects the skin that varies in severity from minor localized patches to complete body coverage. | + | < |
+ | |||
+ | Psoriasis is an autoimmune disease that affects the skin that varies in severity from minor localized patches to complete body coverage. The richness of the skin microbiome and the emerging discrepancies between the microbial composition between health and disease point to a microbial etiology for psoriasis. | ||
The Marshall Protocol treats psoriasis by reactivating the innate immune response. In the course of treatment, patients' | The Marshall Protocol treats psoriasis by reactivating the innate immune response. In the course of treatment, patients' | ||
Line 39: | Line 41: | ||
* **methotrexate** – Methotrexate (MTX) is an antibiotic that interferes with bacteria' | * **methotrexate** – Methotrexate (MTX) is an antibiotic that interferes with bacteria' | ||
* **[[home: | * **[[home: | ||
+ | |||
+ | |||
+ | ===== Patients experiences ===== | ||
+ | |||
+ | |||
+ | < | ||
+ | |||
+ | // | ||
+ | |||
Line 75: | Line 86: | ||
- | {{tag>diseases}} | + | {{tag>disease}} |
===== Notes and comments ===== | ===== Notes and comments ===== |